Rhenman & Partners Asset Management Ab Mirum Pharmaceuticals, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $854 Million
- Q3 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 56,255 shares of MIRM stock, worth $4.02 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
56,255
Previous 65,755
14.45%
Holding current value
$4.02 Million
Previous $3.35 Million
23.25%
% of portfolio
0.48%
Previous 0.44%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
290Shares Held
57.5MCall Options Held
86.1KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million21.07% of portfolio
-
Janus Henderson Group PLC London, X05MShares$357 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$182 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.52MShares$180 Million3.41% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...